These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4354731)

  • 1. On the pathogensis of renovascular hypertension.
    Eide I
    Scand J Clin Lab Invest; 1973 Mar; 31(2):129-32. PubMed ID: 4354731
    [No Abstract]   [Full Text] [Related]  

  • 2. Renovascular hypertension in rats immunized with angiotensin II.
    Eide I
    Circ Res; 1972 Feb; 30(2):149-57. PubMed ID: 4334414
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenic factors involved in renovascular hypertension. State of the art.
    Bumpus FM; Khosla MC
    Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-angiotensin II on blood pressure and sensitivity to angiotensin and renin. Studies on normal, nephrectomized, ureterligated, continuously angiotensin infused, and renal hypertensive rats.
    Bing J; Poulsen K
    Acta Pathol Microbiol Scand A; 1970; 78(1):6-18. PubMed ID: 4315677
    [No Abstract]   [Full Text] [Related]  

  • 5. The second Volhard Lecture: The use of blocking agents to define the functions of the renin--angiotensin system.
    Davis JO
    Clin Sci Mol Med Suppl; 1975 Jun; 2():3s-14s. PubMed ID: 802643
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exchangeable sodium in angiotensinogenic and nonangiotensinogenic renovascular hypertension.
    Albertini R; Binia A; Otsuka Y; Carretero OA
    Hypertension; 1979; 1(6):624-30. PubMed ID: 232088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin. Its release mechanisms and its vasoconstrictive effects in renovascular hypertension.
    Eide I
    J Oslo City Hosp; 1975 Mar; 25(3):37-54. PubMed ID: 1127493
    [No Abstract]   [Full Text] [Related]  

  • 9. Generation of angiotensin II at peripheral vascular level: studies using angiotensin II antisera.
    Swales JD; Thurston H
    Clin Sci Mol Med; 1973 Nov; 45(5):691-700. PubMed ID: 4357224
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Angiotensin inhibition.
    Chobanian AV
    N Engl J Med; 1974 Oct; 291(16):844-5. PubMed ID: 4371423
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal hypertension and angiotensin antibodies.
    Macdonald GJ; Boyd GW; Peart WS
    Am Heart J; 1972 Jan; 83(1):137-9. PubMed ID: 4334675
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system.
    Clough DP; Collis MG; Conway J; Hatton R; Keddie JR
    Am J Cardiol; 1982 Apr; 49(6):1410-4. PubMed ID: 6176106
    [No Abstract]   [Full Text] [Related]  

  • 13. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
    Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
    J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated induction to two-kidney hypertension in rats and renin-angiotensin sensitivity.
    Skulan TW; Brousseau AC; Leonard KA
    Circ Res; 1974 Nov; 35(5):734-41. PubMed ID: 4371192
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of angiotensin conversion and prevention of renal hypertension.
    Miller ED; Samuels AI; Haber E; Barger AC
    Am J Physiol; 1975 Feb; 228(2):448-53. PubMed ID: 235218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension.
    Johansson M; Elam M; Rundqvist B; Eisenhofer G; Herlitz H; Jensen G; Friberg P
    Hypertension; 2000 Oct; 36(4):543-8. PubMed ID: 11040233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB; Atlas SA; Laragh JH
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness to pressor agents in experimental renovascular and steroid hypertension. Effects of converting enzyme inhibitor and nephrectomy.
    Marks ES; Bing RF; Thurston H; Russell GI; Swales JD
    Hypertension; 1982; 4(2):238-44. PubMed ID: 6279494
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):254-62. PubMed ID: 4358386
    [No Abstract]   [Full Text] [Related]  

  • 20. George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis.
    Haber E
    Circulation; 1976 Dec; 54(6):849-61. PubMed ID: 791534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.